decrease of Baht 24.32 million or 91.99%, because of the fluctuation of the price of stocks listed on the stock exchange of Thailand. That was affected by the outbreak of the 2019 coronavirus (COVID-19
fluctuation of the price of stocks listed on stock exchange of Thailand. 2. Underwriting income decreased by Baht 16.53 million due to the following factors : 1.1 Underwriting expenses increased by Baht 33.37
last year, the value of the Company's investment assets this year was effected by the fluctuation of the price of stocks listed on the Stock Exchange of Thailand. Yours sincerely, (Mr. Somboon Fusriboon
other income amounted to Baht 27.71 million, a decrease of Baht 2.82 million or 9.22% over the same period last year, because of the fluctuation of the price of stocks listed on the stock exchange of
154.6 percent when compared to the year 2017 at 236.0 MB. Therefore, the Company would like to clarify the operating results as following essential information: Revenue In the year 2018, the Company and
the operating results as following essential information: Revenue Q2/2018, the Company and its subsidiaries had total revenue of 221.2 MB, increased from Q2/2017 at 1 MB by 0.5 percent that effected
13.6 MB by 71.60 percent when compared to Q3/2017 at 19.1 MB. Therefore, the Company would like to clarify the operating results as following essential information: • Revenue Q3/2018, the Company and its
government has policies to help the cost of living of people at the grassroots level, it focuses on spending of the essential consumer products only. Products of the Company: For Medical Devices; There is
impact from fluctuation of exchange rate . 2. Sales cost to revenue ratio increased by 1.36% (from 96.22% to 93.58%). 3. Gain from foreign exchange increased by 64.87 million baht (from loss 26.43 million
investment in subsidiary of 12 million Baht and allowance for doubtful accounts of 2.78 million Baht. The fluctuation of CPO price mentioned above had reflected the Company's business operation in the